Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Figure 1. Midwest
High Intensity Drug Trafficking Area
Figure 2. Greatest Drug Threat in the Midwest HIDTA Region as Reported by State and Local Law Enforcement Agencies, by Number of Respondents
Figure 3. Methamphetamine Clandestine Laboratory Seizures, by Midwest HIDTA States, 2005-2009
Figure 4. Change in Methamphetamine Laboratory Seizures, Midwest HIDTA Counties, 2008 and 2009
Figure 5. Midwest HIDTA Transportation Infrastructure
Map 1. Methamphetamine Laboratory Seizures in Missouri, by County, 2009
The Midwest High Intensity Drug Trafficking Area (HIDTA) region is a significant transit area for illicit drugs. Its central geographic location is widely used by traffickers who transport methamphetamine, cocaine, heroin, marijuana, and other illicit drugs into the area from Southwest Border and Northern Border locations en route to midwestern and northeastern markets, including Chicago and New York. Mexican drug trafficking organizations (DTOs) dominate wholesale methamphetamine, cocaine, heroin, and marijuana distribution in the HIDTA region. African American, Hispanic, and Caucasian traffickers operate at the midlevel and retail level.
The widespread availability and abuse of methamphetamine and cocaine and associated violence, the local production of methamphetamine, increased Mexican heroin availability and abuse, and controlled prescription drug (CPD) abuse are the most significant drug concerns in the HIDTA region.
The following are significant, strategic drug threat developments in the Midwest HIDTA region:
To Top To Contents
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040
FAX (202) 514-4252
Questions and comments may be directed to Pacific/West Central Unit, Regional Threat Analysis Branch through NDIC.Contacts@usdoj.gov.
End of page.